EYEN: Eyenovia, Inc. Price to Earnings Adjusted for Growth Rate

Corporate company logo of Eyenovia Corp (EYEN)

The Eyenovia, Inc. (EYEN) Optejet ecosystem with custom cartridges relies on external partners for drug synthesis and testing. The peg_co metric visualizes the balance between risk and return, where the value 0.00 describes the current level of asset attractiveness. Highly qualified ophthalmologists and engineers, focused on implementing breakthrough microdosing technologies, drive the success of the FDA expansion.

EYEN Eyenovia, Inc. PEG Multiple (07/04/2022 - 07/03/2025)

Analytical breakdowns for Eyenovia, Inc. (EYEN)

- share price and consensus valuation forecast:
Summary company analytics:EYEN - Eyenovia Corp
Core merchandise of Eyenovia Corp

Professional selection of undervalued assets is based on identifying companies whose P/E multiple is lower than their earnings growth rate. Analyzing this PEG chart, an investor assesses the balance between price and income dynamics, which for Eyenovia, Inc. (EYEN) confirms capitalization potential driven by the implementation of a unique microdosing platform in ophthalmological therapy for myopia and pupil dilation.